Patents for C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550) |
---|
06/14/2001 | CA2362815A1 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect |
06/14/2001 | CA2362675A1 Polymorphic crystalline forms of celecoxib |
06/13/2001 | EP1105359A1 Solid phase synthesis of compounds by carbon-carbon bond forming mitsunobu reactions |
06/13/2001 | EP0656892B1 Herbicidal 2- (4-heterocyclic-phenoxymethyl)phenoxy]-alkanoates |
06/13/2001 | DE19955634A1 Kupplungs-Kondensations-Synthese von Heterocyclen Clutch condensation synthesis of heterocycles |
06/13/2001 | CN1067063C Substituted carboxylic acylaniline derivative and plant disease control agent contg. same as active component |
06/12/2001 | US6245796 Tricyclic pyrrole or pyrazole derivative |
06/12/2001 | US6245766 Method of treating psychiatric conditions |
06/07/2001 | WO2001040195A2 Control of arthropods in animals |
06/07/2001 | WO2001040194A1 Stilbene derivatives, their preparation and their use as antiviral agents |
06/07/2001 | WO2001040193A1 Method for the synthesis of pyrazolines |
06/07/2001 | WO2001028493A3 Small molecule inhibitors of necrosis |
06/06/2001 | EP1104758A1 Acetylene derivatives as anti-inflammatory/analgesic agents |
06/06/2001 | EP1104406A1 Method for preparing 1-alkyl-pyrazol-5-carboxylic acid esters iii |
06/06/2001 | CN1298395A Pyrazolinone derivatives |
06/06/2001 | CN1298390A Arylphenyl-substituted cyclic keto-enols |
06/06/2001 | CN1297889A Preparation of magnesium [(1,5-dimethyl-2-phenyl-3-oxy-2,3-dioxy-1H-pyrazol-4-yl)methylamino] methane sulfonate hexahydrate |
06/06/2001 | CN1066717C 1-arylpyrazoles pesticide |
06/06/2001 | CN1066716C Process for separating carbinols |
06/05/2001 | US6242637 Substituted heterocylic compounds, method of preparing them and pharmaceutical compositions in which they are present |
06/05/2001 | US6242612 Multistage reaction of forming pyrazoles as kinase and cox-2 enzyme inhibitors |
06/05/2001 | US6242609 Ammonium trihalide for halogenation of color couplers and silver halide emulsions |
06/05/2001 | US6242494 Angiogenesis inhibitors, antitumor agents, diabetic retinopathy, and antiinflammatory agents |
06/05/2001 | US6242475 Pesticidal 1-polyarylpyrazoles |
06/05/2001 | US6242470 Rheumatic diseases; antiarthritic agents, antiallergens; irritable bowel syndrome; amidation |
06/05/2001 | US6242422 (Substituted)Acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases |
05/31/2001 | WO2001038325A1 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity |
05/31/2001 | WO2001038302A2 Coupling condensation synthesis of heterocycles |
05/31/2001 | WO2001037826A1 Npyy5 antagonists |
05/31/2001 | WO1999032454A9 Nitrogen containing heteroaromatics with ortho-substituted p1's as factor xa inhibitors |
05/31/2001 | CA2390923A1 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity |
05/30/2001 | EP1103549A1 Photoprotective cosmetic compositions containing aminoamidine derivatives and uses thereof |
05/30/2001 | EP1103243A2 Utilization of aryl(or heteroaryl)azolylcarbinol derivatives in the preparation of a medicament for the treatment of troubles mediated by an excess of substance p |
05/30/2001 | EP1102768A1 Substituted pyrazole derivatives condensed with six-membered heterocyclic rings |
05/30/2001 | EP1102753A2 Pyrazoles as estrogen receptor modulators |
05/30/2001 | CN1297442A 5-aminoindeno [1,2-c] pyrazol-4-ones as anti-cancer and anti-proliferative agents |
05/29/2001 | US6239285 Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems |
05/29/2001 | US6239175 Carbamoyloxy derivatives of mutiline and their use as antibacterials |
05/29/2001 | US6239151 Compounds as inhibitor of tumor necrosis factor alpha release |
05/29/2001 | CA2325783A1 Ultraviolet-protecting cosmetic compounds containing amino- amidine derivatives and uses |
05/25/2001 | WO2001036403A1 Urea derivatives as anti-inflammatory agents |
05/25/2001 | WO2001036390A1 Indazolyloxy propanolamines for improving livestock production |
05/25/2001 | WO2001036389A1 Method for producing n-substituted 2-pyrazoline-5-one |
05/25/2001 | WO2001036388A1 Aza compounds having neuronal activity |
05/25/2001 | WO2001004096A3 N-cycloalkyl-3-alkenylbenzoyl-pyrazole derivatives as herbicides |
05/25/2001 | WO2000077027A3 Serine protease inhibitors |
05/25/2001 | CA2391907A1 Method for producing n-substituted 2-pyrazoline-5-one |
05/25/2001 | CA2390071A1 Aza compounds having neuronal activity |
05/23/2001 | EP1101759A1 Phenylazole compounds, process for producing the same and drugs for hyperlipemia |
05/23/2001 | EP1100805A1 Medicine nitrate salts |
05/23/2001 | EP1100789A1 Substituted benzoylcyclohexandiones |
05/23/2001 | EP1100784A1 Method for the production of n,n'-carbonyl diazoles |
05/23/2001 | EP1100493A1 INDOLE sPLA 2? INHIBITORS |
05/23/2001 | EP1100492A1 INDOLE sPLA 2? INHIBITORS |
05/23/2001 | CN1066138C 4-(arylaminomethylene)-2,4-dihydro-3-pyrazolones |
05/23/2001 | CN1066137C Alpha-phenylbutenic acid methyl esters |
05/22/2001 | US6235911 5-aminopyrazole-4-carboxylate derivative and process for preparing the same |
05/22/2001 | US6235778 Anticoagulants |
05/17/2001 | WO2001034580A1 Heterocycle substituted diphenyl leukotriene antagonists |
05/17/2001 | WO2001034135A2 Oncolytic combinations for the treatment of cancer |
05/17/2001 | CA2391230A1 Heterocycle substituted diphenyl leukotriene antagonists |
05/17/2001 | CA2390789A1 Oncolytic combinations for the treatment of cancer |
05/16/2001 | EP1098885A1 Imidazole compounds and their use as adenosine deaminase inhibitors |
05/16/2001 | EP1098884A1 Il-8 receptor antagonists |
05/16/2001 | EP0820435B1 Method of preparing essentially pure isomers of alpha-bis-oximes |
05/16/2001 | CN1295548A Novel tricyclic compound |
05/16/2001 | CN1295471A Antagonists for treatment of CD11/CD18 adhesion receptor mediated disorders |
05/16/2001 | CN1065744C Treatment of platelet derived growth factor related disorders such as cancers using inhibitors of platelet derived growth receptor |
05/15/2001 | US6232472 Synthesis of 4-[(5-substituted phenyl)-3-substituted-1H-pyrazol-1-yl]benzenesulfonamide |
05/15/2001 | US6232342 Protease inhibitors |
05/15/2001 | US6232337 Useful in the treatment of type ii diabetes and obesity |
05/15/2001 | US6232271 1-Methyl-5-alkylsulfonyl-, 1-methyl-5-alkylsulfinyl- and 1-methyl-5-alkylthio- substituted pyrazolylpyrazoles, processes for their preparation and their use as herbicides |
05/10/2001 | WO2001032663A2 Pyrazolecarboxylic acid tricyclic derivatives, preparation and pharmaceutical compositions containing same |
05/10/2001 | WO2001032629A1 1-benzylpyrazoles-3-carboxylic acid tricyclic derivatives as cannabinoid receptor antagonists |
05/10/2001 | WO2001032628A1 Cyano compounds as factor xa inhibitors |
05/10/2001 | WO2001032627A1 Process of making substituted pyrazoles |
05/10/2001 | WO2001032609A1 Novel compounds having cyano and insecticides and miticides |
05/10/2001 | WO2001032604A1 Activators of soluble guanylate cyclase |
05/10/2001 | WO2001017973A3 Novel herbicides |
05/10/2001 | WO2000010978A8 Method for preparing 1-alkyl-pyrazol-5-carboxylic acid esters iii |
05/10/2001 | CA2389773A1 Activators of soluble guanylate cyclase |
05/09/2001 | EP1097925A1 Novel benzoic acid derivatives and processes for the preparation thereof |
05/09/2001 | EP1097921A1 Phenylhydrazines |
05/09/2001 | CN1294568A Fluorinating agent, process for producing same, and use thereof |
05/09/2001 | CN1065531C Aminotetrazole derivatives useful as nitric oxide synthase inhibotors |
05/08/2001 | US6229022 Reacting carbonyl compounds with hydrazine, its hydrate or salts in the presence of sulfuric acid and iodine or an iodine liberating compound |
05/08/2001 | US6228942 Dehydration to esterify or amidate surface of oxidized or aminated carbon powder or fiber suspended in solution containing a monomer or polymer having amine, hydroxy, and/or viny ether groups |
05/08/2001 | US6228881 Aromatic heterocyclic compounds and their use as anti-inflammatory agents |
05/08/2001 | CA2032141C Pharmaceutically active agents that impede amyloid formation in vivo |
05/03/2001 | WO2001030760A1 Process for preparing 4-trifluoromethylsulphinylpyrazole derivative |
05/03/2001 | WO2001030759A2 Sodium-hydrogen exchanger type 1 inhibitor crystals |
05/03/2001 | WO2001030333A2 Tissue factor antagonists and methods of use thereof |
05/03/2001 | CA2389020A1 Sodium-hydrogen exchanger type 1 inhibitor crystals |
05/03/2001 | CA2387857A1 Tissue factor antagonists and methods of use thereof |
05/02/2001 | EP1095016A1 Sulfur substituted sulfonylaminocarboxylic acid n-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
05/02/2001 | EP1095015A2 Sulfonylamino carboxylic acid n-arylamides as guanylate cyclase activators |
05/01/2001 | US6225331 For therapy and prophylaxis nasal congestion, otitis media, and sinusitis, treating cough, chronic obstructive pulmonary disease (copd) and/or asthma, benign prostatic hypertrophy, cardiovascular disorders, glaucoma, hyperemia, conjunctivitis |
05/01/2001 | US6225023 Sulfonamide compound and method for its production, metal chelate compound employing the sulfonamide compound, and optical recording medium employing the metal chelate compound |
05/01/2001 | CA2001265C Analogs of peptidase substrates |
04/26/2001 | WO2001029008A1 Pyrazole derivatives which modulate human serotonin receptors |